MLABMesa Laboratories, Inc.

$125.99+86% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+3.3 points), but earnings down −754% year on year.

1 good, 1 to watch, 1 neutral
Revenue trend+3% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.

Earnings trend−754% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+3.3 points operating

Trailing-twelve-month operating margin, 9.0% now against 5.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MLAB growing?

Mesa Laboratories, Inc. has grown revenue 4.4% a year over three years and 12% a year over five, with earnings per share compounding at 37%.

+4.4%

Revenue growth, 3-year annual rate · Scientific & Technical Instruments median +7.7% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+12%

Revenue growth, 5-year rate · +4.4% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
+37%

Earnings per share, 3-year rate · revenue +4.4% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
16

Years of annual history on file · FY2011 to FY2026, as filed

Details›
Revenue FY2022
$184M
Revenue FY2023
$219M
Revenue FY2024
$216M
Revenue FY2025
$241M
Revenue FY2026
$249M

Annual income statements as filed with the SEC.